|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Bordetella pertussis IgG ELISA | Amyloid ß Toxic Oligomer ELISA Assay | Anti-Trastuzumab (Herceptin®) ELISA | Bordetella pertussis IgM ELISA | Gd-IgA1 (Galactose-deficient IgA1) ELISA |
| Citations | | | | | |
| Catalog Number | IB05011 | 27709 | TM09015 | IB79851 | 27600 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of human IgG antibodies in serum or plasma directed against Bordetella pertussis and Bordetella parapertussis. For research use only, not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of Amyloid ß Toxic Oligomer in cerebrospinal fluids. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Trastuzumab (Herceptin®, Herclon®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The Bordetella pertussis IgM ELISA is intended for the determination of IgM class antibodies against Bordetella pertussis in human serum or plasma (citrate, heparin). For research use only - not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More |
| Detection Target | Bordetella pertussis IgG | Metanephrine / Normetanephrine | Ranibizumab (Lucentis®) (mAb-based) | Serotonin | Metanephrine / Normetanephrine |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Urine | Aqueous humour | Multiple | Urine |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 3.13 to 200.0 pg/mL | 0 / 30 - 1000 ng/mL | A cut-off control is used for the interpretation of results. | 1.56 to 100.0 ng/mL |
| Sensitivity | > 96% | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 0.33 ng/mL | 0.005 ng/mL x Correction Factor based upon volume of sample used. | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 1 hr 30 mins (incubation) | 2 hours, 15 min. total incubation time. | 1 hr 45 mins (incubation) | 2 hours (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |